China Universal Asset Management Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24M Buy
48,265
+4,363
+10% +$1.93M 1.43% 16
2026
Q1
$19.6M Sell
43,902
-4,145
-9% -$1.93M 1.48% 15
2025
Q4
$21.8M Buy
48,047
+2,933
+7% +$1.26M 1.67% 11
2025
Q3
$17.7M Buy
45,114
+849
+2% +$355K 1.46% 12
2025
Q2
$19.7M Sell
44,265
-4,601
-9% -$2.12M 1.85% 9
2025
Q1
$23.7M Sell
48,866
-3,515
-7% -$1.64M 2.2% 8
2024
Q4
$21.1M Buy
52,381
+2,962
+6% +$1.37M 1.97% 8
2024
Q3
$23M Buy
49,419
+14,564
+42% +$7M 2.53% 7
2024
Q2
$16.3M Sell
34,855
-16,217
-32% -$7.04M 2.3% 8
2024
Q1
$21.3M Buy
51,072
+12,985
+34% +$5.49M 2.71% 5
2023
Q4
$15.5M Buy
38,087
+16,919
+80% +$6.25M 3.02% 3
2023
Q3
$7.36M Buy
21,168
+3,353
+19% +$1.17M 2.13% 7
2023
Q2
$6.27M Buy
17,815
+101
+0.6% +$34K 1.94% 10
2023
Q1
$5.58M Buy
17,714
+928
+6% +$278K 1.89% 11
2022
Q4
$4.85M Sell
16,786
-6,673
-28% -$2.03M 1.95% 11
2022
Q3
$6.79M Sell
23,459
-970
-4% -$279K 2.86% 5
2022
Q2
$6.88M Sell
24,429
-7,610
-24% -$2.04M 2.89% 8
2022
Q1
$8.36M Buy
32,039
+32,024
+213,493% +$7.6M 2.96% 9
2021
Q4
$3K Buy
+15
New +$2.92K ﹤0.01% 91

Other funds holding VRTX

China Universal Asset Management Company's VRTX Position: Q2 2026 in Review

China Universal Asset Management Company increased its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q2 2026, buying an estimated $1.93M and bringing the position to 48,265 shares worth $24M. The position accounts for 1.43% of the portfolio, ranked #16.

China Universal Asset Management Company first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 578 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • China Universal Asset Management Company held 48,265 shares of Vertex Pharmaceuticals worth $24M as of Q2 2026.
  • China Universal Asset Management Company bought 4,363 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.93M.
  • Vertex Pharmaceuticals made up 1.43% of China Universal Asset Management Company's portfolio in Q2 2026, its #16 holding.
  • China Universal Asset Management Company first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 578 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.